OC 14.2 pharmacokinetic characteristics of adamts13 in patients with congenital thrombotic thrombocytopenic purpura: interim results from a phase 3 randomized, controlled, open-label, crossover study - Cataland, S; Patel, M; Mellgård, B (Res Pract Thromb Haemost, 2023)